TRIB Trinity Biotech plc
Healthcare$0.65+7.49%ClosedMarket Cap: $6.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.16
P/S
0.14
EV/EBITDA
-16.24
DCF Value
$-9.28
FCF Yield
-101.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
35.4%
Operating Margin
-25.7%
Net Margin
-85.3%
ROE
68.1%
ROA
-35.6%
ROIC
-15.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $11.1M | 32.1% | $-2.9M | $-17.5M | $— | — |
| FY null | $43.9M | 35.4% | $-11.0M | $-37.5M | $— | — |
| Q3 null | $14.2M | 42.7% | $-536.6K | $-5.1M | $— | — |
| Q2 null | $11.0M | 39.5% | $-3.0M | $-6.0M | $— | — |
| Q1 null | $7.6M | 20.7% | $-4.7M | $-8.8M | $— | — |
| Q4 null | $15.9M | 30.8% | $-11.5M | $-17.0M | $— | — |
| FY null | $61.6M | 34.8% | $-21.2M | $-31.8M | $— | — |
| Q3 null | $15.2M | 35.0% | $-2.6M | $-4.8M | $— | — |
| Q2 null | $15.8M | 36.2% | $-4.1M | $-6.8M | $— | — |
| Q1 null | $14.7M | 34.0% | $-3.0M | $-3.3M | $— | — |
| Q4 null | $13.4M | 30.6% | $-3.5M | $-5.5M | $— | — |
| FY null | $56.8M | 34.2% | $-27.0M | $-24.0M | $— | — |